Skip to main content
  1. Right Decisions
  2. Neurology pathways
  3. Back
  4. Headache
  5. 4. Access to Image in Headache
Announcements and latest updates

Right Decision Service newsletter: September 2024

Welcome to the Right Decision Service (RDS) newsletter for September 2024.

1.Business case for permanent provision of the Right Decision Service from April 2025 onwards

This business case has now been endorsed by the HIS Board and will shortly be submitted to Scottish Government.

2. Management of RDS support tickets

To balance increasing demand with available capacity and financial resource, the RDS team and Tactuum are now working together to  implement closer management of support tickets. As a key part of this, we want to ensure clear, timely and consistent communication with yourselves as requesters.  

Editors will now start seeing new messages come through in response to support ticket requests which reflect this tightening up and improvement of our processes.

Key points to note are:

2.1 Issues confirmed by the RDS and Tactuum teams as meeting the critical/urgent and high priority criteria will continue to be prioritised and dealt with immediately.

Critical/urgent issues are defined as:

  1. The Service as a whole is not operational for multiple users. OR
  2. Multiple core functions of the Service are not operational for multiple users.

Example – RDS website outage.

Please remember to email ann.wales3@nhs.scot and his.decisionsupport@nhs.scot with any critical/urgent issues in addition to raising a support ticket.

High priority issues are defined as:

  1. A single core function of the Service is not operational for multiple users. OR:
  2. Multiple non-core functions of the Service are not operational for multiple users.

Example – Build to app not working.

2.2 Support requests that are outwith the warranty period of 12 weeks since the software was originally developed will not be automatically addressed by Tactuum. The RDS team will consider these requests for costed development work and will obtain estimate of effort and cost from Tactuum for priority issues.

2.3 Support tickets for technical issues that are not classified as bugs will not be automatically addressed by Tactuum. The definition of a bug is ‘a defect in the software that is at variance with documented user requirements.’  Issues that are not bugs will also be considered for costed development work.

The majority of issues currently in support tickets fall into category 2 or 3 above, or both.

2.4 Non-urgent requests that require a deployment (i.e a new release of RDS) will normally be factored into the next scheduled release (currently end of Nov 2024 and end of Feb 2025) unless by special agreement with the RDS team.

Please note that we plan to move in the new year to a new system whereby requests all come to an RDS support portal in the first instance and are triaged from there to Tactuum when appropriate.

We will be organising a webinar in a few weeks’ time to take you through the details of the current support processes and criteria.

3. Next scheduled deployment.

The next scheduled RDS deployment will take place at the end of November 2024.  We are reviewing all outstanding support tickets and feature requests along with estimates of effort and cost to determine which items will be included in this deployment.

We will update you on this in the next newsletter and in the planned webinar about support ticket processes.

4. Contingency arrangements for RDS

Many thanks to those of you who attended our recent webinar on the contingency arrangements being put in place to prevent future RDS outages as far as possible and minimise impact if they do occur.  Please contact ann.wales3@nhs.scot if you would like a copy of the slides from this session.

5. Transfer of CKP pathways to RDS

The NES clinical knowledge pathway (CKP) publisher is now retired and the majority of pathways supported by this tool have been transferred to the RDS. Examples include:

NHS Lothian musculoskeletal pathways

NHS Fife rehabilitation musculoskeletal pathways

NHS Tayside paediatric pathways

6. Other new RDS toolkits

Include:

Focus on frailty (from HIS Frailty improvement programme)

NHS GGC Money advice and support

If you would like to promote one of your new toolkits through this newsletter, please contact ann.wales3@nhs.scot

To go live imminently:

  • Focus on dementia
  • NHS Lothian infectious diseases toolkit
  • Dumfries and Galloway Adult Support and Protection procedures
  • SIGN guideline – Prevention and remission of type 2 diabetes

 

7. Evaluation projects

We have recently analysed the results of a survey of users of the Scottish Palliative Care Guidelines toolkit.  Key findings from 61 respondents include:

  • Most respondents (64%) are frequent users of the toolkit, using it either daily or weekly. A further 25% use it once or twice per month.
  • 5% of respondents use the toolkit to deliver direct patient care and 82% use it for learning
  • Impact on practice and decision-making was rated as very high, with 80% of respondents rating these at a 4-5 on a 5 point scale.
  • Impact on time saving was also high, with 74% of respondents rating it from 3-5.
  • 74% also reported that the toolkit improved their knowledge and skills, rating these at 4-5 on the Likert scale

Key strengths identified included:

  • The information is useful, succinct, and easy to understand (31%).
  • Coverage is comprehensive (15%)
  • All information is readily accessible in one place and users value the offline access via mobile app (15%)
  • Information is reliable, evidence-based and up to date (13%)

Users highlighted key areas for improvement in terms of navigation and search functionality. The survey was very valuable in enabling us to uncover the specific issues affecting the user experience. Many of these can be addressed through content management approaches. The issues identified with search results echo other user feedback, and we are costing improvements with a view to implementation in the next RDS deployment.

8.RDS High risk prescribing (polypharmacy) decision support embedded in Vision and EMIS primary care E H R systems

This decision support software, sponsored by Scottish Government Effective Prescribing and Therapeutics Division,  is now available for all primary care clinicians across NHS Tayside. Board-wide implementation is also planned for NHS Lothian, and NHS GGC, NHS Ayrshire and Arran and NHS Dumfries and Galloway have initial pilots in progress. The University of Dundee has been commissioned to evaluate impact of this decision support software on prescribing practice.

9. Video tutorials for RDS editors

Ten bite-size (5 mins or less) video tutorials for RDS editors are now available in the “Resources for providers of RDS tools” section of the RDS.  These cover core functionality including Save and preview, content page and media management, password management and much more.

10. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Wednesday 23rd October 4-5 pm
  • Tuesday 29th October 11 am -12 pm

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

 

Warning

Background

Most patients presenting to health services with headaches have primary headache (up to 95% presenting to primary care and over 50% presenting to A&E). The most common primary headache is migraine, making up the majority of these patients.  

Most patients with primary headache do not require investigation. Evidence based guidelines on neuroimaging in patients with non-acute headache estimate a rate of 0.2% of relevant intracranial abnormalities in patients diagnosed with migraine.  

Neuroimaging is often considered in patients with migraine for the following reasons: unusual, prolonged or persistent aura, increasing frequency severity or change in migraine clinical features, worst migraine, migraine with brainstem aura, hemiplegic migraine, migraine without aura.  

  

Neuroimaging is also, not uncommonly, carried out in patients for reassurance, both physician and patient. While some patients / clinicians may request neuroimaging hoping to ease anxiety, the initial reduction in anxiety is lost at 1 year follow up in patients with chronic headache. 

 

Apparently asymptomatic incidental abnormalities of potential significance are problematic and are an unintended consequence of brain imaging in clinical situations where the prevalence of any relevant finding is likely to be low. 

There is no evidence that imaging is more likely to reveal meaningful abnormalities in patients with primary headache compared to the general population. Several studies affirm that routine neuroimaging for migraine is more likely to identify incidental abnormalities than identify serious problems, potentially leading to more anxiety and leading to further investigations and follow up. 

 

The incidental abnormality pick-up rate on MRI scans can be up to 10%, with a chances of detecting an infarct in 1 in 14, aneurysm in 1 in 55 and a benign tumour such as a meningioma in 1 in 62. 

RED FLAGS

RED FLAGS 

Most patients do not have serious secondary headache. Red flags indicate the need for urgent assessment to exclude a secondary cause. The most consistent indicators for serious secondary causes for headache are: 

  1. Thunderclap (sudden onset) headache (consider SAH and its differential) 
  2. New focal neurological deficit on examination (e.g. hemiparesis) 
  3. Systemic features (considering GCA, infection such as meningitis or encephalitis, etc) 
  4. New progressive headache in a patient over 50 (most headaches presenting in patients over 50 are benign, but there is an increased risk of secondary pathology with increasing age) 

 

Headache suggesting the possibility of a brain tumour 

  1. New headache plus sub-acute progressive focal neurology 
  2. New headache plus seizures 
  3. New headache with personality or cognitive change not suggestive of dementia, with no psychiatric history and confirmed by witness 

AMBER FLAGS

Features that may indicate a secondary cause but may also be seen in primary headaches: 

  1. Changes in headache intensity with changes of posture (upright consider low pressure / headache when lying flat consider high pressure) 
  2. Worsening/Triggering headache with Valsalva (e.g. coughing, straining) 
  3. Atypical aura (duration >1 hour or including motor weakness) 
  4. Progressive headache (worsening over weeks or longer) 
  5. Head trauma within the last month 
  6. Previous history of cancer or HIV 
  7. Re-attendance to A&E or GP surgery with progressively worsening headache severity or frequency 

Consider a secondary cause if any of these are present 

 

Features that do not help to differentiate primary from secondary headaches are: 

  1. Severity  
  2. Treatment response  

GREEN FLAGS

Features that are supportive of a diagnosis of primary headache: 

  1. Recurrent episodic headache, particularly with features of migraine 
  2. Long history of daily headache 

If there are no concerning features then it is appropriate to manage these patients for migraine. Other features that are pointers to migraine include a previous migraine history and a family history of migraine. 

GP open access CT scan

GP open access CT scan for Headache (where available) should be available for: 

  • Adult patients above the age of 16 years 
  • No red flags  
  • Normal neurological examination 

Patients should not be routinely imaged for migraine 

Patients with red flags should be referred as emergency / urgently to secondary care for appropriate assessment / investigation 

Patients with amber flags should be considered for urgent referral to secondary care for investigations, unless the primary care physician decides that a GP open access CT is more appropriate 

Referral to secondary care for open access CT brain imaging

If there is diagnostic uncertainty or concern about a secondary cause, at this point consider open access CT as an alternative to secondary referral. For some patients, CT may not be the most appropriate investigation e.g. ESR/CRP/Plasma viscosity in GCA and LP (after appropriate imaging) in Idiopathic Intracranial Hypertension. 

Dealing with incidental findings from CT and MRI scans 

There must be a clear local pathway for management of patients who have an abnormality detected on their GP open access CT scan.  

Evidence base – MRI in the general population 

The overall prevalence of incidental brain findings in 2000 asymptomatic volunteers aged 46-97 using high resolution MRI was more than 10%. Asymptomatic brain infarcts were present in 7.2% and brain aneurysms in 1.8%. Benign tumours (mostly meningiomas) were present in 1.6%, arachnoid cysts in 1.1% and Chiari malformations in 0.9% 

 

A further metaanalysis subdivided incidental findings on MRI scans in 19559 participants into  

 

Potentially symptomatic or treatable abnormalities 

  • Neoplasms 
  • Cysts 
  • Structural vascular abnormalities 
  • Inflammatory lesions 
  • Others – chiari malformations, neoplasms 

  

Markers of cerebrovascular disease 

  • White matter abnormalities 
  • Silent brain infarcts 
  • Brain microbleeds 

 

The meta-analysis reported an incidental abnormality pickup rate of 1.7% using low resolution MRI and 4.3% using high resolution MRI. The age range of patients was 3-97 which perhaps explained the lower pick up rate. They also reported an age related increase in white matter hyperintensities and brain infarcts and also in all neoplastic incidental brain findings. 

Evidence base – Neuroimaging in patients with migraine 

CT 

In a study of 1111 patients with headache who were scanned, 10.8% scans were abnormal, the majority in patients above the age of 40. This included 4% with a brain infarct and 1.6% with a primary neoplasm 

In a study looking at direct access CT brain scan for patients with a chronic headache, abnormal findings were reported in 10.5% 

 

MRI 

The HUNT study reported that patients with any headache disorder did not have a higher incidence of any intracranial abnormality as compared to the non-headache population except for non-specific white matter changes. 

Editorial Information

Last reviewed: 11/10/2023

Next review date: 01/04/2025